LRRC32 产品
(Leucine Rich Repeat Containing 32 (LRRC32))
Categories
This gene encodes a type I membrane protein which contains 20 leucine-rich repeats. Alterations in the chromosomal region 11q13-11q14 are involved in several pathologies. [provided by RefSeq, Jul 2008].
antibodies-online.com stands for high-quality research products. Search, find and order tools with extensive validation data, images, references. Our scientific customer service is always at your disposal if you have any questions about the selection or application of our products.
Featured LRRC32 Categories
LRRC32 抗体
High quality antibodies with extensive validation data.
LRRC32 ELISA试剂盒
Reliable ELISA kits for a wide range of species.
LRRC32 蛋白
Proteins for various applications incl. WB, ELISA, IF etc.
Recommended LRRC32 抗体
Product
Reactivity
Application
Validations
Cat. No.
Quantity
Datasheet
Reactivity
Rat
Application
WB, IHC, IP, ICC
Validations
- (5)
Cat. No.
ABIN7443611
Quantity
100 μL
Datasheet
Datasheet
Reactivity
Human, Mouse
Application
WB, IHC, ELISA
Validations
- (8)
Cat. No.
ABIN3028542
Quantity
0.4 mL
Datasheet
Datasheet
Reactivity
Human, Mouse
Application
WB, IHC (p)
Validations
- (5)
Cat. No.
ABIN390588
Quantity
400 μL
Datasheet
Datasheet
Recommended LRRC32 ELISA试剂盒
Product
Reactivity
Analytical Method
Validations
Cat. No.
Quantity
Datasheet
Reactivity
Mouse
Analytical Method
Quantitative Sandwich ELISA
Validations
Cat. No.
ABIN6730679
Quantity
96 tests
Datasheet
Datasheet
Recommended LRRC32 蛋白
Product
Reactivity
Source
Validations
Cat. No.
Quantity
Datasheet
Reactivity
Human
Source
HEK-293 Cells
Validations
- (1)
Cat. No.
ABIN6964156
Quantity
100 μg
Datasheet
Datasheet
Reactivity
Mouse
Source
Escherichia coli (E. coli)
Validations
Cat. No.
ABIN7580733
Quantity
100 μg
Datasheet
Datasheet
Reactivity
Human
Source
Mammalian Cells
Validations
Cat. No.
ABIN7577995
Quantity
100 μg
Datasheet
Datasheet
Latest Publications for our LRRC32 Products
: "Effect of GARP on osteogenic differentiation of bone marrow mesenchymal stem cells via the regulation of TGFβ1 in vitro." in: PeerJ, Vol. 7, pp. e6993, (2019) (PubMed).: "Regulatory CD4 T cells inhibit HIV-1 expression of other CD4 T cell subsets via interactions with cell surface regulatory proteins." in: Virology, Vol. 516, pp. 21-29, (2018) (PubMed).
: "Monoclonal antibodies against GARP/TGF-β1 complexes inhibit the immunosuppressive activity of human regulatory T cells in vivo." in: Science translational medicine, Vol. 7, Issue 284, pp. 284ra56, (2015) (PubMed).
: "Canonical Wnt signaling in megakaryocytes regulates proplatelet formation." in: Blood, Vol. 121, Issue 1, pp. 188-96, (2013) (PubMed).
: "Soluble GARP has potent antiinflammatory and immunomodulatory impact on human CD4⁺ T cells." in: Blood, Vol. 122, Issue 7, pp. 1182-91, (2013) (PubMed).
: "GARP is regulated by miRNAs and controls latent TGF-β1 production by human regulatory T cells." in: PLoS ONE, Vol. 8, Issue 9, pp. e76186, (2013) (PubMed).
: "GARP regulates the bioavailability and activation of TGF?." in: Molecular biology of the cell, Vol. 23, Issue 6, pp. 1129-39, (2012) (PubMed).
: "Regulatory T cells with reduced repressor capacities are extensively amplified in pulmonary sarcoid lesions and sustain granuloma formation." in: Clinical immunology (Orlando, Fla.), Vol. 140, Issue 1, pp. 71-83, (2011) (PubMed).
: "GARP: a key receptor controlling FOXP3 in human regulatory T cells." in: Journal of cellular and molecular medicine, Vol. 13, Issue 9B, pp. 3343-57, (2010) (PubMed).
: "Therapeutic potential of FOXP3(+) regulatory T cells and their interactions with dendritic cells." in: Human immunology, Vol. 70, Issue 5, pp. 294-9, (2009) (PubMed).
Synonyms and alternative names related to LRRC32
leucine rich repeat containing 32 (LRRC32), leucine rich repeat containing 32 (Lrrc32), AI426318, D7H11S833E, D11S833E, D11S833Eh, EG434215, GARP, GarpProtein level used designations for LRRC32
- leucine rich repeat containing 32
- leucine-rich repeat-containing protein 32
- leucine-rich repeat-containing protein 32-like
- garpin
- glycoprotein A repetitions predominant
You are here:
